1. Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy
   Cariad Chester et al, 2015, Frontiers in Immunology CrossRef
2. HLA allele-specific expression: Methods, disease associations, and relevance in hematopoietic stem cell transplantation
   Tiira Johansson et al, 2022, Frontiers in Immunology CrossRef
3. Tumor-Associated T-Lymphocytes and Macrophages are Decreased in Endometrioid Endometrial Carcinoma with MELF-Pattern Stromal Changes
   Dmitry Aleksandrovich Zinovkin et al, 2018, Cancer Microenvironment CrossRef
4. Monospecific and Polyreactive Monoclonal Antibodies against Human Leukocyte Antigen-E: Diagnostic and Therapeutic Relevance
   Mepur H. Ravindranath et al, 2021, Monoclonal Antibodies CrossRef
5. KLRC1 knockout overcomes HLA-E-mediated inhibition and improves NK cell antitumor activity against solid tumors
   Alice Mac Donald et al, 2023, Frontiers in Immunology CrossRef
6. High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer
   Cheng Sun et al, 2017, OncoImmunology CrossRef
7. Harnessing NK cells for cancer immunotherapy: immune checkpoint receptors and chimeric antigen receptors
   Nayoung Kim et al, 2021, BMB Reports CrossRef
8. Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
   Aviad Ben-Shmuel et al, 2020, Frontiers in Immunology CrossRef
9. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment
   Michelle Hanus et al, 2021, Frontiers in Immunology CrossRef
10. Implications of NKG2A in immunity and immune-mediated diseases
    Xiaotong Wang et al, 2022, Frontiers in Immunology CrossRef
11. Immunotherapy in Lung Cancer: Current Landscape and Future Directions
    Hirva Mamdani et al, 2022, Frontiers in Immunology CrossRef
12. NK Cells Equipped With a Chimeric Antigen Receptor That Overcomes Inhibition by HLA Class I for Adoptive Transfer of CAR-NK Cells
    Xiaoxuan Zhuang et al, 2022, Frontiers in Immunology CrossRef
13. NK Cell-Based Immune Checkpoint Inhibition
    Muhammad Khan et al, 2020, Frontiers in Immunology CrossRef